Literature DB >> 22186370

Orexin-1 receptor mediation of cocaine seeking in male and female rats.

Luyi Zhou1, Shannon M Ghee, Clifford Chan, Li Lin, Michael D Cameron, Paul J Kenny, Ronald E See.   

Abstract

Previous studies have shown that female rats exhibit enhanced cocaine seeking during multiple phases of cocaine addiction compared with males. The orexin/hypocretin system recently has been implicated in drug addiction in male rats. Based on the known sex differences in cocaine addiction, in the current study we examined orexin-mediated cocaine seeking during self-administration, extinction, and reinstatement in age-matched male (initial weight 250-300 g) and female (initial weight 175-225 g) Sprague-Dawley rats by using the orexin-1 receptor (OX1R) antagonist 1-(2-methylbenzoxazol-6-yl)-3-[1,5]naphthyridin-4-yl urea (SB-334867) (10-30 mg/kg). OX1R blockade had no effect on established cocaine self-administration, but attenuated cocaine seeking during extinction in both male and female rats. It is noteworthy that OX1R blockade potently attenuated cue-induced reinstatement in males but had no effect on females. SB-334867 also reduced cocaine seeking during pharmacological stress-induced (yohimbine, 2.5 mg/kg) and yohimbine + cue-induced reinstatement in both sexes. SB-334867 failed to affect reinstatement induced by cocaine (10 mg/kg) in either male or female rats, but selectively reduced cocaine + cue-induced reinstatement only in males. In separate experiments examining basal and cocaine-induced locomotion, SB-334867 attenuated locomotion in both male and female rats. Finally, assessment of plasma and brain levels of SB-334867 showed that estrus females had slightly higher plasma levels than diestrus females, but no overall sex differences or estrous cycle differences were observed in plasma or brain SB-334867 concentrations. These results show that OX1R signaling plays a role in mediating cocaine seeking, but differs between the sexes for cue-induced reinstatement.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22186370      PMCID: PMC3286310          DOI: 10.1124/jpet.111.187567

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  39 in total

1.  Gene expression and protein distribution of the orexin-1 receptor in the rat brain and spinal cord.

Authors:  G J Hervieu; J E Cluderay; D C Harrison; J C Roberts; R A Leslie
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

2.  Possible involvement of orexin in the stress reaction in rats.

Authors:  T Ida; K Nakahara; T Murakami; R Hanada; M Nakazato; N Murakami
Journal:  Biochem Biophys Res Commun       Date:  2000-04-02       Impact factor: 3.575

Review 3.  It could be habit forming: drugs of abuse and striatal synaptic plasticity.

Authors:  Gregory L Gerdeman; John G Partridge; Carl R Lupica; David M Lovinger
Journal:  Trends Neurosci       Date:  2003-04       Impact factor: 13.837

4.  Orexin-A infusion in the locus ceruleus triggers norepinephrine (NE) release and NE-induced long-term potentiation in the dentate gyrus.

Authors:  Susan G Walling; David J Nutt; Margaret D Lalies; Carolyn W Harley
Journal:  J Neurosci       Date:  2004-08-25       Impact factor: 6.167

5.  1,3-Biarylureas as selective non-peptide antagonists of the orexin-1 receptor.

Authors:  R A Porter; W N Chan; S Coulton; A Johns; M S Hadley; K Widdowson; J C Jerman; S J Brough; M Coldwell; D Smart; F Jewitt; P Jeffrey; N Austin
Journal:  Bioorg Med Chem Lett       Date:  2001-07-23       Impact factor: 2.823

6.  Prepro-orexin and orexin receptor mRNAs are differentially expressed in peripheral tissues of male and female rats.

Authors:  O Jöhren; S J Neidert; M Kummer; A Dendorfer; P Dominiak
Journal:  Endocrinology       Date:  2001-08       Impact factor: 4.736

7.  Enhancement of cue-induced reinstatement of cocaine-seeking in rats by yohimbine: sex differences and the role of the estrous cycle.

Authors:  Matthew W Feltenstein; Alisha R Henderson; Ronald E See
Journal:  Psychopharmacology (Berl)       Date:  2011-02-11       Impact factor: 4.530

8.  Sex differences in cocaine-induced behavioral responses, pharmacokinetics, and monoamine levels.

Authors:  Eugene D Festa; Scott J Russo; Farhad M Gazi; Tipyamol Niyomchai; Lynne M Kemen; Shen-Nan Lin; Rodger Foltz; Shirzad Jenab; Vanya Quinones-Jenab
Journal:  Neuropharmacology       Date:  2004-04       Impact factor: 5.250

9.  Determination of the estrous cycle phases of rats: some helpful considerations.

Authors:  F K Marcondes; F J Bianchi; A P Tanno
Journal:  Braz J Biol       Date:  2003-02-11       Impact factor: 1.651

Review 10.  Orexin: a link between energy homeostasis and adaptive behaviour.

Authors:  Takeshi Sakurai
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2003-07       Impact factor: 4.294

View more
  41 in total

1.  Differential orexin/hypocretin expression in addiction-prone and -resistant rats selectively bred for high (HiS) and low (LoS) saccharin intake.

Authors:  Nathan A Holtz; Natalie E Zlebnik; Marilyn E Carroll
Journal:  Neurosci Lett       Date:  2012-06-02       Impact factor: 3.046

Review 2.  Sex Differences in Animal Models: Focus on Addiction.

Authors:  Jill B Becker; George F Koob
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

3.  Hypocretin/orexin antagonists decrease cocaine self-administration by female rhesus monkeys.

Authors:  Richard W Foltin; Suzette M Evans
Journal:  Drug Alcohol Depend       Date:  2018-05-25       Impact factor: 4.492

Review 4.  Modeling cocaine relapse in rodents: Behavioral considerations and circuit mechanisms.

Authors:  Mitchell R Farrell; Hannah Schoch; Stephen V Mahler
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2018-01-03       Impact factor: 5.067

Review 5.  A Decade of Orexin/Hypocretin and Addiction: Where Are We Now?

Authors:  Morgan H James; Stephen V Mahler; David E Moorman; Gary Aston-Jones
Journal:  Curr Top Behav Neurosci       Date:  2017

Review 6.  Stress-Induced Reinstatement of Drug Seeking: 20 Years of Progress.

Authors:  John R Mantsch; David A Baker; Douglas Funk; Anh D Lê; Yavin Shaham
Journal:  Neuropsychopharmacology       Date:  2015-05-15       Impact factor: 7.853

Review 7.  Multiple roles for orexin/hypocretin in addiction.

Authors:  Stephen V Mahler; Rachel J Smith; David E Moorman; Gregory C Sartor; Gary Aston-Jones
Journal:  Prog Brain Res       Date:  2012       Impact factor: 2.453

Review 8.  Systems level neuroplasticity in drug addiction.

Authors:  Matthew W Feltenstein; Ronald E See
Journal:  Cold Spring Harb Perspect Med       Date:  2013-05-01       Impact factor: 6.915

Review 9.  Orexin/hypocretin based pharmacotherapies for the treatment of addiction: DORA or SORA?

Authors:  Shaun Yon-Seng Khoo; Robyn Mary Brown
Journal:  CNS Drugs       Date:  2014-08       Impact factor: 5.749

10.  Hypocretin Neurotransmission Within the Central Amygdala Mediates Escalated Cocaine Self-administration and Stress-Induced Reinstatement in Rats.

Authors:  Brooke E Schmeichel; Melissa A Herman; Marisa Roberto; George F Koob
Journal:  Biol Psychiatry       Date:  2016-06-16       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.